You have 1 action to finish to complete your account. Craft your experience by picking your interest on the Personalisation Page
On demand events

IFOS 2023 | Type 2 Inflammation and Clinically Relevant Improvements in CRSwNP

Dr. Stella Lee and Profs. Peter Hellings and Wytske Fokkens discuss type 2 inflammation, partnering with patients to improve outcomes, and real-world data on biologic effectiveness in CRSwNP.

Stella  Lee
Peter Hellings
Wytske Fokkens
Stella Lee +2 more

On demand materials

Learning objectives

  • Review the inflammatory endotypes observed in CRSwNP, zooming in on the key role of type 2 cytokines, IL-4, IL-13, and IL-5
  • Understand the underappreciated burden on health-related quality of life, and the importance of bringing patients into the decision-making process
  • Define the concepts of statistical significance and clinical importance and the advantages of considering clinically important symptom improvements in patients with CRSwNP
  • Review evidence of improvements in olfaction with surgery and biologics from real-world effectiveness studies and randomized controlled trials and safety of biologics in patients with CRSwNP

About these experts